Anthony D. Sandler, M.D.
Affiliations: | Children's National Medical Center, Washington, DC, United States |
Google:
"Anthony Sandler"Parents
Sign in to add mentor| Richard H. Pearl | fellowship/program director | 1996 | Hospital for Sick Chidren |
Children
Sign in to add trainee| Jarod McAteer | division chief | 2016-2018 | Children's National Medical Center |
| Jun Tashiro | division chief | 2018-2020 | Children's National Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Eranki A, Srinivasan P, Ries M, et al. (2019) High Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Abou-Antoun TJ, Nazarian J, Ghanem A, et al. (2018) Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance. Plos One. 13: e0189711 |
| Chakrabarti L, Morgan C, Sandler AD. (2015) Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model. Plos One. 10: e0129237 |
| Chakrabarti L, Wang BD, Lee NH, et al. (2013) A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma. Plos One. 8: e83521 |
| Srinivasan P, Snyder JA, Shashurin A, et al. (2013) Abstract 2771: Development of a non-thermal plasma model for neuroblastoma treatment. Cancer Research. 73: 2771-2771 |
| Chakrabarti L, Abou-Antoun T, Vukmanovic S, et al. (2012) Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance. Frontiers in Oncology. 2: 82 |
| Intra J, Zhang XQ, Williams RL, et al. (2011) Immunostimulatory sutures that treat local disease recurrence following primary tumor resection. Biomedical Materials (Bristol, England). 6: 011001 |
| Miles SA, Sandler AD. (2009) CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Advanced Drug Delivery Reviews. 61: 275-82 |
| Azuhata T, Scott D, Griffith TS, et al. (2006) Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. Journal of Pediatric Surgery. 41: 1431-40 |
| Ohashi K, Kobayashi G, Fang S, et al. (2006) Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma. Journal of Pediatric Surgery. 41: 1361-8 |